Chase Pharmaceuticals Corporation
Chase Pharmaceuticals is an early stage, product based, specialty pharmaceutical company, focused on the identification and initial clinical development of better medications for the treatment of Alzheimer’s disease.
Chase Pharmaceuticals, Thomas N. Chase, John M. Siebert, neurologic, psychiatric, central nervous system, pharmaceutical, pharmaceutical products, Alzheimer, drug development, clinical development, Phase I, Phase II, early stage, start up, Washington, DC
Is this your site? Certify your site and update informations
